OmniActive's Lutemax Free Lutein Approved for Infant Nutrition

FDA Recognizes Lutemax Free Lutein for Infant Formula
GRAS Clearance Revolutionizes Early Life Nutrition
OmniActive Health Technologies has achieved a crucial regulatory milestone with the U.S. Food and Drug Administration (FDA) recognizing its Lutemax Free Lutein for incorporation into infant formula. This approval marks a significant step forward for a premium ingredient intended for one of the strictest food categories: nutrition for infants.
This FDA acknowledgment underscores the safety and effectiveness of Lutemax Free Lutein, offering infant formula manufacturers an innovative opportunity to cater to the rising demand for products that foster brain and vision development in young children.
"Lutein is a key carotenoid prevalent in breast milk. With this regulatory approval, infant formulas can provide a composition closer to what nursing infants receive. This opens up an entirely new avenue for OmniActive, enhancing our commitment to safety and leading scientific progress. Our partners in early life nutrition now have a unique lutein resource to boost developmental health in infants," shares Dr. Deshanie Rai, Vice President of Global Regulatory and Advocacy at OmniActive.
Significance of Lutemax Free Lutein
Lutein plays a vital role in cognitive and visual health, being a predominant carotenoid in both the macula of the eye and the human brain. The body's accumulation of lutein initiates during pregnancy and continues to be crucial throughout life. Supported by numerous studies, including findings from Lutemax Kids and Lutemax 2020, lutein has shown significant benefits in enhancing visual clarity, shielding against harmful blue light, and supporting cognitive functions such as memory and attention.
Dr. Tanya Altmann, a pediatric specialist and medical advisor for OmniActive’s Lutein for Every Age campaign, highlights that "lutein is vital during the first year of life, a period characterized by rapid growth and the formation of neural connections. Breastfeeding naturally provides some lutein, but formula-fed infants may miss out on this essential nutrient. Lutemax Free Lutein steps in to fill this gap, ensuring that a larger number of infants can benefit from this critical nutrient during their development."
Infant Nutrition and Safety
Infants are unable to synthesize lutein on their own, making dietary sources crucial for their development. Including Lutemax Free Lutein in infant formula effectively addresses this nutritional need. The formula provided by OmniActive presents this ingredient in a stable and safe format for both infants and adults.
Adam Adelmann, Chief Commercial Officer at OmniActive, comments, "This milestone represents far more than just regulatory endorsement; it reflects the dedication of our team and 20-year commitment to the health benefits of the Lutemax portfolio. Brands can now offer a reliable lutein source for infant formula, delivering a safe and transparent option for parents when breastfeeding isn't feasible. Our ongoing mission centers on informing everyone about lutein's essential role, supporting health from before birth and through every stage of life."
Commitment to Quality
Lutemax Free Lutein is sourced from premium marigolds, an edible flower known for its rich lutein content, cultivated under sustainable conditions from non-GMO seeds. The ingredient is produced through an integrated supply chain, providing traceability and transparency regarding production practices.
With a rich legacy of research and innovation, the Lutemax range has set the benchmark for promoting eye and brain health throughout every stage of life. For further information about OmniActive and the Lutemax line, please visit their website.
About OmniActive
Founded in 2005, OmniActive is dedicated to enhancing health through innovative, scientifically supported natural solutions. The company's portfolio features scientifically validated Specialty Actives and a broad selection of natural Botanical Actives, catering to global clients in dietary supplements, functional foods, and beverages. OmniActive operates offices in both India and New Jersey.
Frequently Asked Questions
What is Lutemax Free Lutein?
Lutemax Free Lutein is a premium lutein ingredient recognized for its contribution to infant formula, focusing on brain and eye health.
Why is lutein important for infants?
Lutein is a crucial nutrient that supports cognitive and visual development, especially in the early stages of an infant's life when growth is rapid.
How does Lutemax Free Lutein benefit formula-fed babies?
It provides a stable and safe source of lutein that may be lacking in breast milk for formula-fed infants, helping them receive this essential nutrient.
What distinguishes Lutemax Free Lutein?
It is sourced from marigolds, produced sustainably, and offers superior stability, making it an ideal choice for infant nutrition.
What is OmniActive's commitment to health solutions?
OmniActive prioritizes research and development in natural health ingredients, aiming to improve quality of life through science-backed nutraceuticals.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.